Research programme: ATP-binding cassette transporter activators for organ toxicity in immunosuppression - Limerick BioPharmaAlternative Names: LIM-0723
Latest Information Update: 16 Jul 2016
At a glance
- Originator Limerick BioPharma
- Class Small molecules
- Mechanism of Action ATP-binding cassette transporter stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Transplant-rejection(Adjunctive treatment) in USA (PO)